ACBM Acro Biomedical Co., Ltd.

Fundamentals / CIK 0001622996 / USD

Acro Biomedical Co., Ltd. reported $0 in revenue and a net loss of $140K for the trailing twelve months ended June 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACBM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2025), reported in USD.

$9.58M$4.79M$0-$15.52MFY 2017 Revenue: $510KFY 2017 Net Income: -$2.2K2017FY 2018 Revenue: $8.01MFY 2018 Net Income: $420K2018FY 2019 Revenue: $1.35MFY 2019 Net Income: -$371K2019FY 2019 Revenue: $194KFY 2019 Net Income: -$372K2019FY 2020 Revenue: $688KFY 2020 Net Income: -$117K2020FY 2021 Revenue: $1.20MFY 2021 Net Income: -$7.70M2021FY 2022 Revenue: $658KFY 2022 Net Income: -$15.87M2022FY 2023 Revenue: $0FY 2023 Net Income: -$8.81M2023FY 2024 Revenue: $0FY 2024 Net Income: -$42K2024FY 2025 Revenue: $0FY 2025 Net Income: -$101K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Sep 30 Sep 30
Revenue $0 $0 $0 $658K $1.20M $688K $194K $1.35M $8.01M $510K
Cost of Revenue -- -- $0 $518K $938K $529K $181K $1.22M $7.18M $459K
Gross Profit -- -- $0 $140K $260K $159K $12K $135K $833K $51K
Research & Development -- $0 $4.79M $10.08M $5.29M -- -- -- -- --
Selling, General & Admin $154K $38K $3.52M $5.93M $2.67M $290K $435K $577K $318K $53K
Total Operating Expenses $154K $38K $8.80M $16.01M $7.95M $290K $435K $577K $318K $53K
Operating Income -$154K -$38K -$8.80M -$15.87M -$7.69M -$130K -$423K -$442K $516K -$2.2K
Interest Expense -- -- $3.2K $1.7K $893 $1.1K -- -- -- --
Income Before Tax -$101K -$42K -$8.81M -$15.87M -- -$136K -$425K -$444K $512K -$2.2K
Income Tax Expense $0 $0 $0 $0 $0 -$18K -$53K -$73K $92K $0
Net Income -$101K -$42K -$8.81M -$15.87M -$7.70M -$117K -$372K -$371K $420K -$2.2K
Basic EPS -- -- -- -- -$0.14 $0.00 -$0.01 -$0.01 $0.01 $0.00
Diluted EPS $0.00 $0.00 -$0.15 -$0.26 -- $0.00 -$0.01 -$0.01 $0.01 $0.00
Basic Shares Outstanding -- -- -- -- -- 47.8M 47.8M 47.8M 47.7M 47.2M
Diluted Shares Outstanding 60.0M 60.0M 60.0M 60.0M 53.8M 47.8M 47.8M 47.8M 47.7M 47.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development -- -- -- -- -- -- $0 $0
Selling, General & Admin $18K $60K $16K $115K $14K $8.9K $9.5K $9.1K
Total Operating Expenses $18K $60K $16K $115K $14K $8.9K $9.5K $9.1K
Operating Income -$18K -$60K -$16K -$115K -$14K -$8.9K -$9.5K -$9.1K
Interest Expense -- -- -- -- -- $22K -- $6.1K
Income Before Tax -- -- $43K -$118K -$16K -$10K -$11K -$10K
Income Tax Expense -- -- $0 $0 $0 $0 $0 $0
Net Income -$21K -$44K $43K -$118K -$16K -$10K -$11K -$10K
Diluted EPS $0.00 $0.00 -- $0.00 $0.00 $0.00 -- $0.00
Diluted Shares Outstanding 60.0M 60.0M -- 60.0M 60.0M 60.0M -- 60.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents -- -- -- $5.9K $95K $18K $911 $1.5K $1.1K $37K
Cash & Short-Term Investments -- -- -- $5.9K $95K $18K $911 $1.5K $1.1K $37K
Accounts Receivable, Net -- -- $0 $638K $598K $0 -- -- -- --
Inventory -- -- -- -- $0 $938K $879K $1.06M $1.15M --
Total Current Assets $14K $5.1K $1.6K $658K $706K $973K $879K $1.07M $1.48M $548K
Total Non-Current Assets $0 $27K $57K $30K $55K $25K $53K $0 $5.0K $0
Total Assets $14K $32K $58K $687K $761K $998K $932K $1.07M $1.48M $548K
Accounts Payable $56K -- -- -- -- -- -- -- -- --
Deferred Revenue (Current) $20K $20K $20K $20K $20K -- -- $116K -- --
Other Current Liabilities -- -- $89K $79K -- -- -- -- -- --
Total Current Liabilities $401K $327K $289K $201K $92K $312K $112K $196K $241K $37K
Total Non-Current Liabilities $0 $0 $27K $0 $26K $0 $22K $0 $0 $0
Total Liabilities $401K $327K $315K $201K $117K $312K $134K $196K $241K $37K
Total Debt (incl. Leases) -- $27K $52K $26K $50K $24K $46K -- -- --
Common Stock $60K $60K $60K $60K $60K $48K $48K $48K $48K $48K
Retained Earnings -$32.76M -$32.66M -$32.62M -$23.81M -$7.94M -$239K -$121K -$45K $325K -$94K
Total Stockholders' Equity -$387K -$295K -$257K $486K $644K $686K $798K $874K $1.24M $511K
Total Equity -$387K -$295K -$257K $486K $644K $686K $798K $874K $1.24M $511K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Total Current Assets $3.6K $3.9K $14K $4.3K $40K $4.9K $5.1K $701
Total Non-Current Assets $0 $0 $0 $0 $14K $20K $27K $38K
Total Assets $3.6K $3.9K $14K $4.3K $53K $25K $32K $39K
Accounts Payable $63K -- $56K -- -- -- -- --
Deferred Revenue (Current) $0 $0 $20K $20K $20K $20K $20K $20K
Total Current Liabilities $448K $431K $401K $437K $371K $329K $327K $317K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $6.9K
Total Liabilities $448K $431K $401K $437K $371K $329K $327K $324K
Total Debt (incl. Leases) -- -- -- -- $14K $18K $27K $33K
Common Stock $60K $60K $60K $60K $60K $60K $60K $60K
Retained Earnings -$32.82M -$32.80M -$32.76M -$32.80M -$32.68M -$32.67M -$32.66M -$32.65M
Total Stockholders' Equity -$445K -$427K -$387K -$433K -$318K -$304K -$295K -$286K
Total Equity -$445K -$427K -$387K -$433K -$318K -$304K -$295K -$286K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Sep 30 Sep 30
Net Income -$101K -$42K -$8.81M $15.87M -$7.70M -$117K -$372K -$371K $420K -$2.2K
Stock-Based Compensation -- $0 $8.06M $15.71M $7.65M $0 $148K $300K $7.4K --
Change in Receivables -- $0 $158K -$40K $598K $0 -- -- -- --
Change in Inventory -- -- -- $0 -$938K $59K $181K $87K -$666K -$481K
Change in Payables -- -- -- $50K $1.5K $900 -- -- -- --
Operating Cash Flow -$196K -$37K -$15K -$147K $299K -$199K -$60K $80K -$140K -$463K
Common Stock Issued -- -- -- -- -- -- -- -- -- $500K
Financing Cash Flow $200K $37K $10.0K $58K -$222K $217K $23K -$79K $105K $498K
Net Change in Cash $3.6K $100 -$5.5K -$89K $77K $17K -$37K $324 -$36K $34K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$21K -$44K $43K -$118K -$16K -$10K -$11K -$10K
Change in Receivables -- -- -- -- -- -- $0 $0
Operating Cash Flow -$11K -$50K -$25K -$54K -$94K -$23K -$11K -$6.3K
Financing Cash Flow $10K $50K $25K $59K $94K $22K $10K $6.1K
Net Change in Cash -$225 -$225 -$225 $4.3K -$225 -$225 -$225 -$225

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Sep 30 Sep 30
Gross Margin -- -- -- 21.3% 21.7% 23.2% 6.2% 10.0% 10.4% 10.0%
Operating Margin -- -- -- -2410.0% -642.5% -19.0% -218.4% -32.6% 6.4% -0.4%
Net Profit Margin -- -- -- -2410.2% -642.8% -17.1% -192.0% -27.4% 5.2% -0.4%
Return on Equity (ROE) -- -- -- -3263.2% -1195.9% -17.1% -46.6% -42.4% 33.8% -0.4%
Return on Assets (ROA) -717.4% -132.3% -15066.2% -2308.6% -1011.4% -11.8% -39.9% -34.7% 28.3% -0.4%
Current Ratio 0.04x 0.02x 0.01x 3.27x 7.71x 3.12x 7.88x 5.46x 6.14x 14.83x
Quick Ratio -- -- -- 3.20x 7.71x 0.11x 0.01x 0.05x 1.38x 1.00x
Debt to Equity -- -- -- 0.05x 0.08x 0.04x 0.06x -- -- --
Revenue Growth (YoY) -- -- -100.0% -45.0% +74.1% +255.5% -- -83.1% +1471.5% --
Gross Profit Growth (YoY) -- -- -100.0% -45.9% +62.8% +1217.8% -- -83.8% +1534.1% --
Operating Income Growth (YoY) -- -- -- -- -- -- -- -185.6% -- -105.2%
Net Income Growth (YoY) -- -- -- -- -- -- -- -188.3% -- --
EPS Growth (YoY) -- -- -- -- -- -- -- -200.0% -- --
Operating Cash Flow Growth (YoY) -- -- -- -149.3% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Assets (ROA) -3849.0% -3475.8% -717.4% -3570.3% -87.8% -164.2% -132.3% -128.9%
Current Ratio 0.01x 0.01x 0.04x 0.01x 0.11x 0.01x 0.02x 0.00x
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -1411.6%
Source: SEC EDGAR CompanyFacts (CIK 0001622996) · from March 31, 2015 Data through June 30, 2026 · synced Nov 21, 2026, 05:12 UTC · Open in terminal